-Reuters
Related Posts
Pharvaris’ Promising Oral Treatment Solutions For Treating Swollen Blood Vessels – Analyst Sees 35% Upside
Wedbush has initiated coverage on Pharvaris N.V. (NASDAQ: PHVS), noting that the company stands out as one of the players with their strategy to develop and advance oral therapeutic options in both the acute and prophylactic settings for hereditary angioedema (HAE).
Fidelity D & D Bancorp, Inc. Announces Increase Of Quarterly Dividend From $0.36 To $0.38 Per Share
The Board of Directors of Fidelity D & D Bancorp, Inc. (NASDAQ:FDBC), parent company of The Fidelity Deposit and Discount Bank, announce their declaration of the Company's fourth quarter dividend of $0.38 per share,
Competitor Analysis: Evaluating Cadence Design Sys And Competitors In Software Industry
In today’s rapidly changing and fiercely competitive business landscape, it is vital for investors and industry enthusiasts to…